Story perspectives

Intestine, Not Liver, Drives Metformin’s Glucose-Lowering Effect

5/13/2026

Summary

Northwestern Finds Gut

Northwestern researchers found metformin lowers blood glucose mainly by acting in the intestine.
Intestinal metformin concentrations reach millimolar levels, 10-100 times higher than in the liver.
Gut cells with yeast enzyme NDI1 showed a reduced glucose-lowering response, indicating complex I inhibition forces glycolysis and glucose uptake.
Metformin lowers citrulline, raises GDF15, and mealtime dosing aligns peak gut levels with post-meal spikes, while berberine acts similarly but lacks testing.

Summary

Metformin Reduces Citrulline

Metformin users gain less muscle and aerobic fitness because intestinal citrulline levels drop.
Citrulline serves as the precursor to nitric oxide, which widens blood vessels for exercising muscle.
Reduced citrulline likely lowers nitric-oxide production, providing a mechanistic link to poorer exercise outcomes.
Metformin-induced gut-derived GDF15 suppresses appetite via the brain, contributing to modest weight loss.

1 of 2

Northwestern Finds Gut

Northwestern researchers found metformin lowers blood glucose mainly by acting in the intestine.
Intestinal metformin concentrations reach millimolar levels, 10-100 times higher than in the liver.
Gut cells with yeast enzyme NDI1 showed a reduced glucose-lowering response, indicating complex I inhibition forces glycolysis and glucose uptake.
Metformin lowers citrulline, raises GDF15, and mealtime dosing aligns peak gut levels with post-meal spikes, while berberine acts similarly but lacks testing.

1 / 2